Home
Pear Therapeutics

Pear Therapeutics Market Share Analysis for June 2026

pioneer in prescription digital therapeutics (pdts) with the goal of providing better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

Health > Biotechnology and Pharmaceuticals

Domainpeartherapeutics.com

Year Founded2013

Employees201 - 500

Annual Revenue$10M - $15M

Pear Therapeutics

Pear Therapeutics (including company regionals)

peartherapeutics.com

See more website traffic and engagement information

Pear Therapeutics Revenue up to June 2026 is 10M - 15M

revenue generated by Pear Therapeutics top domains

Pear Therapeutics top domains revenue over 3 years

Revenue for Pear Therapeutics top domains

peartherapeutics.com10M - 15M

See more with Sales Intelligence

Total visits to Pear Therapeutics's top domains

Understand Pear Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Pear Therapeutics's top domains

Analyze Pear Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Pear Therapeutics's top domains

See how Pear Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Pear Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

google.comCompany NameGoogleEmployees> 10001HQUnited States, California, Mountain ViewAnnual revenue> $1BTotal visits86.3BComputers Electronics and Technology > Search Engines

Top technologies used by Pear Therapeutics

These are the website technologies, by industry, used by Pear Therapeutics top domains

Advertising (7)

DoubleClick

Widget (4)

Twemoji

Email Services (3)

G Suite

Marketing (3)

Google Marketing Platform

More Technologies

11

See all

News & Signals from Pear Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPear Therapeutics, Inc. is developing digital therapeutic solution targeting patients with substance abuse disorders.They collaborated with Pear Therapeutics to develop a digital therapeutic solution targeting patients with substance abuse disorders, aiming to enhance clinical outcomes.

NewsPear Therapeutics, Inc. is developing Somryst on Jan 1st '23.Pear Therapeutics developed a product called Somryst, which was acquired by Nox Health after Pear filed for bankruptcy in 2023.

NewsPear Therapeutics, Inc. went public on May 23rd '23.Better's demise has followed a similar path to that seen with Pear Therapeutics, another digital health company that went down the IPO route, but filed for bankruptcy last year.